BioMed Research International / 2015 / Article / Tab 1

Research Article

Clinical Impact of the KL-6 Concentration of Pancreatic Juice for Diagnosing Pancreatic Masses

Table 1

Patients’ characteristics.

Pancreatic inflammatory lesionIPMNIPMCPDAC

Number of patients (M/F)12 (8/4)19 (15/4)5 (1/4)34 (18/16)
Mean age, y (range)65.6 (36–80)71.7 (55–82)79.6 (77–83)69.9 (45–83)
Mean size of mass, mm (range)30.0 (4–60)28.2 (20–50)31.6 (6–56)
Tumor marker (serum, SD)
 CEA2.8 ± 2.33.6 ± 2.82.1 ± 2.021.4 ± 70.5
 CA19-910.4 ± 9.09.3 ± 30.917.9 ± 17.31534.0 ± 3729.2a
 Span-17.1 ± 5.912.5 ± 10.138.8 ± 41.6935.0 ± 4163.4
 DUPAN233.4 ± 30.859.1 ± 80.653.6 ± 55.02404.7 ± 10451.1
 KL-6249.2 ± 121.9294.6 ± 210.3280.4 ± 262.7453.6 ± 503.7b

Materials of which final diagnosis was obtained by operation or clinical follow-up.
compared with pancreatic inflammatory lesion.
compared with pancreatic inflammatory lesion.